Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer: A Review

Timothy D. Malouff, Sunil Krishnan, Christopher L. Hallemeier, Michael G. Haddock, Bradford S. Hoppe, Chris Beltran, Anita Mahajan, Daniel M. Trifiletti

Research output: Contribution to journalReview articlepeer-review


Pancreatic cancer is the fourth most common cause of cancer-related morality worldwide, and the prognosis remains poor despite aggressive therapy. Carbon ion radiotherapy has favorable radiobiological and physical characteristics in the treatment, including a higher linear energy transfer and higher relative biological effectiveness, which increase the cell kill while potentially reducing toxicities to nearby normal tissues. Although small, early clinical studies have shown promise in both the resectable and unresectable settings to improve local control and overall survival while minimizing toxicities. Currently, there are several trials, including 2 sponsored by institutions in the United States, investigating the role of carbon ion radiotherapy for the treatment of locally advanced pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)737-743
Number of pages7
Issue number6
StatePublished - Jul 1 2020


  • hadron
  • heavy
  • pancreas
  • particle
  • tumor

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology


Dive into the research topics of 'Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer: A Review'. Together they form a unique fingerprint.

Cite this